Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:150-156
Published online before print November 3, 2005, doi: 10.1161/01.ATV.0000194096.89476.73
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/1/150    most recent
01.ATV.0000194096.89476.73v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, H.
Right arrow Articles by Linton, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, H.
Right arrow Articles by Linton, M. F.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Gene therapy
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:150.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Macrophage Apolipoprotein E Reduces Atherosclerosis and Prevents Premature Death in Apolipoprotein E and Scavenger Receptor–Class BI Double-Knockout Mice

Hong Yu; Wenwu Zhang; Patricia G. Yancey; Mark J. Koury; Youmin Zhang; Sergio Fazio; MacRae F. Linton

From the Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Departments of Medicine (H.Y., W.Z., P.G.Y., Y.Z., S.F., M.F.L.), Hematology (M.J.K), Pharmacology (M.F.L.), and Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn.

Correspondence to MacRae F. Linton or Sergio Fazio, 383 PRB, 2220 Pierce Ave, Vanderbilt University Medical Center, Nashville, TN 37232-6300. E-mail macrae.linton{at}vanderbilt.edu or sergio.fazio@vanderbilt.edu

Objective— Mice null for both apolipoprotein (apo)E and scavenger receptor (SR)-BI (DKO) develop severe hypercholesterolemia, occlusive coronary atherosclerosis, myocardial infarction, and premature death. The current study examines the ability of macrophage apoE to improve the dyslipidemia, reduce atherosclerosis, and rescue the lethal phenotype of DKO mice.

Methods and Results— Initially, bone marrow transplantation (BMT) was unsuccessful, because the DKO mice died from a rapidly fatal anemia 3 to 5 days after lethal irradiation. Therefore, probucol was used to rescue the DKO mice during BMT and was discontinued 2-weeks after BMT, allowing successful reconstitution with donor marrow. Twelve male apoE–/–SR-BI–/– mice fed 0.5% probucol in a chow diet were lethally irradiated and transplanted with either wild-type (WT) or DKO bone marrow. Two-weeks after BMT, apoE was detected in serum in WT->DKO mice, and mean serum cholesterol levels were reduced by 70% versus DKO->DKO mice. Lipoprotein profiles and HDL subpopulations in WT->DKO mice were similar to apoE+/+SR-BI–/–->DKO mice and resembled those of SR-BI–/– mice. In WT->DKO mice, aortic atherosclerosis was reduced by 88% to 90% versus DKO->DKO mice. Furthermore, the DKO->DKO mice died &8 weeks after BMT, whereas WT->DKO mice exhibited a life span >40 weeks after BMT.

Conclusions— Macrophage apoE is able to rescue the lethal phenotype of apoE–/–SR-BI–/– mice by improving the dyslipidemia and dramatically reducing atherosclerotic lesion development.

Mice null for apolipoprotein E and scavenger receptor class BI develop severe hypercholesterolemia, occlusive coronary atherosclerosis, myocardial infarction, and premature death, The current study indicates that macrophage apolipoprotein E is able to rescue the lethal phenotype of apolipoprotein E–/– scavenger receptor class BI–/– mice by preventing severe dyslipidemia and atherosclerotic lesion development.


Key Words: macrophages • apolipoprotein E • SR-BI • cholesterol • atherosclerosis




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Guo, Z. Song, M. Li, Q. Wu, D. Wang, H. Feng, P. Bernard, A. Daugherty, B. Huang, and X.-A. Li
Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response
J. Biol. Chem., July 24, 2009; 284(30): 19826 - 19834.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Nakanishi, R. Vikstedt, S. Soderlund, M. Lee-Rueckert, A. Hiukka, C. Ehnholm, M. Muilu, J. Metso, J. Naukkarinen, L. Palotie, et al.
Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity
J. Lipid Res., February 1, 2009; 50(2): 183 - 192.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. G. Yancey, W. G. Jerome, H. Yu, E. E. Griffin, B. E. Cox, V. R. Babaev, S. Fazio, and M. F. Linton
Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI
J. Lipid Res., May 1, 2007; 48(5): 1140 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Saika, K. Ikeda, O. Yamanaka, K. C. Flanders, Y. Okada, T. Miyamoto, A. Kitano, A. Ooshima, Y. Nakajima, Y. Ohnishi, et al.
Loss of Tumor Necrosis Factor {alpha} Potentiates Transforming Growth Factor {beta}-mediated Pathogenic Tissue Response during Wound Healing
Am. J. Pathol., June 1, 2006; 168(6): 1848 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X.-A. Li, L. Guo, R. Asmis, M. Nikolova-Karakashian, and E. J. Smart
Scavenger Receptor BI Prevents Nitric Oxide-Induced Cytotoxicity and Endotoxin-Induced Death
Circ. Res., April 14, 2006; 98(7): e60 - e65.
[Abstract] [Full Text] [PDF]